Common Contracts

EX-10.49 4 a12-8655_1ex10d49.htm EX-10.49

u.s. Co-Promotion Agreement • May 5th, 2020 • New York

• Contract Type
  u.s. Co-Promotion Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

U.S. CO-PROMOTION AGREEMENT AFFYMAX, INC. and TAKEDA PHARMACEUTICALS U.S.A., INC. February 24, 2012

u.s. Co-Promotion Agreement • May 9th, 2012 • Affymax Inc • Pharmaceutical preparations • New York

• Contract Type
  u.s. Co-Promotion Agreement
• Filed
  May 9th, 2012
• Company
  Affymax Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This U.S. CO-PROMOTION AGREEMENT (the “Agreement”) is entered into on February 24, 2012 (the “Effective Date”) between AFFYMAX, INC., a Delaware corporation, with its principal place of business at 4001 Miranda Avenue, Palo Alto, CA 94304, U.S.A. (“Affymax”), and TAKEDA PHARMACEUTICALS U.S.A., INC., a company incorporated under the laws of Delaware, with a place of business at One Takeda Parkway, Deerfield, IL 60015, U.S.A. (“TPUSA”). Affymax and TPUSA are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.